Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation

Simon J Johnston1, Kwok-Leung Cheung2

  • 1School of Medicine, University of Nottingham, Nottingham, UK.

Oncology and Therapy
|July 24, 2020
PubMed

Insights

Hormonal manipulation targeting oestrogen receptor (ER) is key in treating most breast cancers. This review outlines endocrine therapy principles and evidence to guide optimal clinical strategies.

Area of Science:

  • Oncology
  • Endocrinology
  • Genetics

Background:

  • Oestrogen receptor (ER) drives 70% of breast cancers.
  • Endocrine therapies targeting ER are highly effective anticancer strategies.
  • Novel targeted agents are increasingly combined with endocrine therapies.

Purpose of the Study:

  • To outline principles of hormonal manipulation in breast cancer.
  • To review key evidence underpinning current endocrine therapy clinical practice.
  • To guide optimal strategy selection in evolving treatment landscapes.

Main Methods:

  • Review of established endocrine therapy principles.
  • Analysis of clinical evidence for current breast cancer treatment.
  • Discussion of combination therapy benefits and risks.

Main Results:

  • Endocrine therapies targeting ER are a cornerstone of breast cancer treatment.
  • Combination therapies offer potential for maximized efficacy.
  • Balancing efficacy gains against increased side effect risks is crucial.

Conclusions:

  • Understanding hormonal manipulation is vital for breast cancer management.
  • Interpreting clinical data is essential for selecting optimal endocrine therapy strategies.
  • The role of endocrine therapy in breast cancer continues to expand, requiring careful consideration of treatment options.

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
5.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K